Integra LifeSciences Holdings Corporation provides revenue guidance for the second quarter of 2024. For the second quarter 2024, the Company expects reported revenues in the range of $411 million to $416 million, representing reported growth of 7.8% to 9.1% and organic growth of 1.3% to 2.6%.
Integra LifeSciences Holdings Corporation
Equities
IART
US4579852082
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.8 USD | -1.00% | -0.32% | -29.28% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.28% | 2.45B | |
-2.26% | 181B | |
+2.05% | 108B | |
-1.31% | 69.41B | |
+14.65% | 46.61B | |
-6.69% | 45.85B | |
+7.97% | 42.61B | |
+18.60% | 30.71B | |
+16.92% | 25.63B | |
-6.87% | 23.32B |
- Stock Market
- Equities
- IART Stock
- News Integra LifeSciences Holdings Corporation
- Integra LifeSciences Holdings Corporation Provides Revenue Guidance for the Second Quarter of 2024